Case Studies > Centralizing Biologics Data for a Growing Company

Centralizing Biologics Data for a Growing Company

Company Size
11-200
Region
  • America
Country
  • United States
Product
  • Benchling Bioregistry
Tech Stack
  • Data Centralization
Implementation Scale
  • Enterprise-wide Deployment
Impact Metrics
  • Digital Expertise
  • Productivity Improvements
Technology Category
  • Platform as a Service (PaaS) - Data Management Platforms
Applicable Industries
  • Life Sciences
Applicable Functions
  • Product Research & Development
Services
  • Data Science Services
About The Customer
Inhibrx is a company that develops multivalent costimulatory agonists, checkpoint inhibitors, and therapeutics to invert the tumor microenvironment toward local immune activation. They are a growing company that is constantly developing new products and solutions. They have a team of scientists who work on various projects and experiments. However, they were facing challenges in tracking their work and data due to the lack of a formal tracking system. This was causing inefficiencies and difficulties in finding the right information when needed.
The Challenge
Inhibrx, a company that develops multivalent costimulatory agonists, checkpoint inhibitors, and therapeutics to invert the tumor microenvironment toward local immune activation, was facing several challenges. They did not have a formal tracking system, which resulted in plasmid maps being distributed across multiple scientists’ computers. This made it difficult to find the right plasmid map and often involved walking through the lab to find the right scientist. Additionally, spreadsheets were used to track requests and information about plasmids, which required extensive manual search and limited user compliance. Experimental notes were taken using a shared paper lab notebook, making it difficult to find experimental details and extract insights.
The Solution
Inhibrx implemented the Benchling Bioregistry, a central source of truth for plasmids that enforces uniqueness constraints to ensure data integrity. This allowed them to have a reliable registration system for their plasmids. They also used Benchling to interlink experimental details. Scientists could link batches to relevant experiments, so their notes directly reflected all of the products and data they’ve generated. Inhibrx also built out a new process development team and onboarded them onto Benchling, where they could access the data of upstream teams. This streamlined their IND filing process as they could use Benchling Lab Notebook entries and unique Lab Notebook IDs to file for IND, saving months of time and effort.
Operational Impact
  • Reliable registration of plasmids through the Benchling Bioregistry
  • Interlinked experimental details allowing for more accurate and efficient note-taking
  • Successful setup and onboarding of a new process development team onto Benchling
  • Streamlined IND filing process through the use of Benchling Lab Notebook entries and unique Lab Notebook IDs
Quantitative Benefit
  • Saved months of time and effort in the IND filing process

Case Study missing?

Start adding your own!

Register with your work email and create a new case study profile for your business.

Add New Record

Related Case Studies.

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.